Search Results - "STRASBURGER, C. J"
-
1
Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
Published in The journal of clinical endocrinology and metabolism (01-07-2012)“…Context: Oral administration of a novel octreotide formulation enabled its absorption to the systemic circulation, exhibiting blood concentrations comparable…”
Get full text
Journal Article -
2
A consensus on the diagnosis and treatment of acromegaly complications
Published in Pituitary (01-09-2013)“…In March 2011, the Acromegaly Consensus Group met to revise and update the guidelines on the diagnosis and treatment of acromegaly complications. The meeting…”
Get full text
Journal Article -
3
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study
Published in European journal of endocrinology (01-01-2007)“…Objective: The GH receptor antagonist pegvisomant is a highly effective new treatment option in acromegaly. The German Pegvisomant Observational Study (GPOS)…”
Get full text
Journal Article -
4
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire
Published in European journal of endocrinology (01-05-2008)“…Chronic exposure to hypercortisolism has significant impact on patient's health and health-related quality of life (HRQoL), as demonstrated with generic…”
Get full text
Journal Article -
5
Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach
Published in Pituitary (01-10-2015)“…Purpose Initial successful surgical treatment of pituitary adenomas is crucial to reach long-term remission. Indocyanine green (ICG) videoangiography (VA) is…”
Get full text
Journal Article -
6
Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR
Published in Experimental and clinical endocrinology & diabetes (01-03-2011)“…To assess the efficacy of different dosing intervals of lanreotide, Somatuline Autogel® (Lan-ATG) 120 mg in patients with acromegaly, previously treated with…”
Get more information
Journal Article -
7
The German ACROSTUDY: past and present
Published in European journal of endocrinology (01-11-2009)“…Pivotal studies have demonstrated that pharmacotherapy with pegvisomant (Somavert) is a highly effective treatment for acromegaly. Since clinical experience…”
Get full text
Journal Article -
8
Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study
Published in European journal of endocrinology (01-07-2009)“…In treatment-resistant patients with acromegaly, pharmacotherapy with pegvisomant (Somavert) is a highly effective option. However, safety concerns have been…”
Get full text
Journal Article -
9
Postoperative Evaluation of Patients with Acromegaly: Clinical Significance and Timing of Oral Glucose Tolerance Testing and Measurement of (Free) Insulin-Like Growth Factor I, Acid-Labile Subunit, and Growth Hormone-Binding Protein Levels
Published in The journal of clinical endocrinology and metabolism (01-12-2005)“…Context: It is not exactly known when patients with acromegaly should be evaluated for cure after transsphenoidal adenomectomy (TA). Objective: The objective…”
Get full text
Journal Article -
10
Generation of Human Soluble Leptin Receptor by Proteolytic Cleavage of Membrane-Anchored Receptors
Published in Endocrinology (Philadelphia) (01-10-2001)“…The leptin receptor (ObR) exists in multiple isoforms. In rodents, a soluble isoform is generated by alternative splicing; but in humans, there is no mRNA…”
Get full text
Journal Article -
11
Impact of Experimental Blockade of Peripheral Growth Hormone (GH) Receptors on the Kinetics of Endogenous and Exogenous GH Removal in Healthy Women and Men
Published in The journal of clinical endocrinology and metabolism (01-12-2002)“…Organs that respond to and metabolize GH are enriched in cognate high-affinity receptors. However, whether isologous receptors mediate the de facto access of…”
Get full text
Journal Article -
12
High-Dose Leptin Activates Human Leukocytes Via Receptor Expression on Monocytes
Published in The Journal of immunology (1950) (15-10-2001)“…Leptin is capable of modulating the immune response. Proinflammatory cytokines induce leptin production, and we now demonstrate that leptin can directly…”
Get full text
Journal Article -
13
Systemic Regulation of Distraction Osteogenesis: A Cascade of Biochemical Factors
Published in Journal of bone and mineral research (01-07-2002)“…This study investigates the systemic biochemical regulation of fracture healing in distraction osteogenesis compared with rigid osteotomy in a prospective in…”
Get full text
Journal Article -
14
Diagnosis and treatment of acromegaly complications
Published in Journal of endocrinological investigation (01-12-2003)“…The Pituitary Society in conjunction with the European Neuroendocrine Association held a consensus workshop to develop guidelines for diagnosis and treatment…”
Get full text
Journal Article -
15
Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement
Published in The Journal of steroid biochemistry and molecular biology (01-12-1992)“…Cortisol 3-(o-carboxymethyl)oxime (C3-CMO) and a commercially available biotin-hydrazide derivative were used to synthesize a C3-CMO-biotin conjugate. C3-CMO…”
Get more information
Journal Article -
16
Detection of doping with human growth hormone
Published in The Lancet (British edition) (13-03-1999)Get full text
Journal Article -
17
Retraction Note: Influence of hypobaric hypoxia on leptin levels in men
Published in International Journal of Obesity (17-09-2024)Get full text
Journal Article -
18
Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men
Published in The journal of clinical endocrinology and metabolism (01-07-2001)“…The present clinical study implements a novel interventional strategy of short-term profound and selective blockade of GH receptors to reduce plasma…”
Get full text
Journal Article -
19
Salivary cortisol levels throughout childhood and adolescence : relation with age, pubertal stage, and weight
Published in Pediatric research (01-04-1995)“…The measurement of cortisol in saliva has become a reliable tool for both the scientist and the clinician for studying adrenal cortical function in the adult…”
Get full text
Journal Article -
20
Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis
Published in European journal of endocrinology (01-02-2006)“…Objective: The new GH receptor antagonist pegvisomant is the most effective medical therapy to normalize IGF-I levels in patients with acromegaly. Based on…”
Get full text
Journal Article